New bone graft mix shows promise for dental implants in severe jaw atrophy
NCT ID NCT07186166
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This completed study tested a bone graft mixture (30% hydroxyapatite and 70% beta-tricalcium phosphate) combined with platelet-rich fibrin in 42 patients with severe jaw bone loss (less than 4 mm height). After 6 months, core biopsies showed new bone formation, allowing dental implant placement. The study suggests this graft may help patients who otherwise lack enough bone for implants.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
bone graft mixture (30% hydroxyapatite and 70% beta-tricalcium phosphate) combined with platelet-rich fibrin
What this could lead to
If successful, this approach could improve dental implant success in patients with severe jaw bone loss.
What could go wrong
This is a small, single-arm study with no comparison group. Results may not apply to all patients, and long-term implant success is not yet proven.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMPLANT SITE REACTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Can Tho University of Medicine and Pharmacy
Can Tho, 90000, Vietnam